LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Wednesday reported a loss of $4.4 million in its fiscal third quarter.
On a per-share basis, the Latham, New York-based company said it had a loss of 11 cents. Earnings, adjusted for one-time gains and costs, came to 3 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The medical device maker posted revenue of $72 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $70.6 million.
AngioDynamics expects full-year results to range from a loss of 34 cents per share to a loss of 31 cents per share, with revenue in the range of $285 million to $288 million.
AngioDynamics shares have increased 5.5% since the beginning of the year. The stock has climbed 66% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANGO at https://www.zacks.com/ap/ANGO
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.